DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery

Information source: Kuopio University Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Atrial Fibrillation; Cardiac Surgery

Intervention: metoprolol, amiodarone (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Kuopio University Hospital

Summary

The aim of the study is to test the efficiency of intravenous administration of metoprolol versus intravenous administration of amiodarone in the prevention of atrial fibrillation after cardiac surgery.

Clinical Details

Official title: Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Primary outcome: Incidence of atrial fibrillation

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- elective CABG and aortic valve patients in cardiac surgery,

- previous use of betablocker therapy

Exclusion Criteria:

- previous atrial fibrillation or flutter,

- thyroid disease,

- uncontrolled heart failure,

- II or III degree atrioventricular block

Locations and Contacts

Halonen jari, Kuopio FIN- 70211, Finland
Additional Information

Starting date: August 2007
Last updated: November 23, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017